MCMi in Action: Protecting National Health and Security
![Images representing FDA's Medical Countermeasures Initiative, including an organ-on-chip, a lab exercise in the MCMi professional development program, "Emergency" sign, and medical countermeasures including a PCR test and pill bottles.](https://public4.pagefreezer.com:443/content/FDA/19-07-2022T08:45/https://www.fda.gov/files/styles/main_image_medium/public/MCMi_activities_collage2.jpg?itok=_gZCfasB)
FDA is committed to protecting national health and security. We are working to foster the development and availability of medical products that will be needed to counter a public health emergency, no matter its origin.
The FDA Medical Countermeasures Initiative (MCMi) mission includes:
-
A robust MCM regulatory science program that creates the data necessary to support regulatory decision-making
-
A collaborative effort to modernize the legal, regulatory and policy framework establishes effective policies and mechanisms to facilitate timely access to available MCMs
-
A professional development program that helps FDA meets the regulatory challenges posed by new science and technology developments